Artificial Intelligence

AI like 'Claude Mythos' creates exploits in hours while ransomware turns corporate. Experts say Zero Trust is the only way to fight back.

Kayne Anderson's latest distribution offers a ~7.3% yield, but the real story is its tax-advantaged structure. What does this signal about the sector?

The 2026 CPRS ACE Awards celebrate top campaigns, revealing how AI, strategic creativity, and new talent are reshaping Canada's public relations landscape.

The creative workflow integrator has achieved a critical security milestone, streamlining procurement and boosting assurance for its enterprise client base.

The new institutional platform replaces opaque "chat window" deals with real-time rates, automated risk management, and a unified marketplace.

As Meta's AI revolutionizes advertising, C Squared Social triples its media team, betting on a new systems-driven model to win in the algorithmic era.

Datavault AI acquires CyberCatch for $136M, merging AI compliance with a quantum-resistant platform to tackle future cyber threats and strict regulations.

As Rekor Systems preps its Q1 2026 results, investors are watching to see if its AI-driven strategy and cost cuts can sustain momentum and narrow losses.

AI startup Panoplai won a top industry award for its digital twin tech, proving AI in market research is now about real results, not just experiments.

The infrastructure giant saw net income jump 56% as it capitalizes on relentless data center demand, navigating a weak housing market with strategic moves.

With new FDA clearance, Zeta Surgical's portable AI navigation system could bring millimeter-precision brain surgery to any hospital, not just elite centers.

A new software-only approach from Retia Medical promises to turn routine monitors into powerful cardiac tools, democratizing critical care without new hardware.

A Q1 GAAP loss masks record assets, strong inflows, and major strides in digital finance, as the firm executes a strategic pivot toward future growth.

Noema Pharma's investigational drug cendifensine not only cut hot flashes by 92% but also aided weight loss and mood, promising a new non-hormonal era.

With $2.5M in seed funding, Hamilton's Stoked Bio is using a novel AI platform to tackle the world's toughest diseases, from superbugs to brain cancer.

Riverwood Capital hires veteran Mac Hofeditz to lead capital formation, signaling a major push to fund its disciplined, AI-driven investment strategy.

LG launches its 2026 lineup in Canada, featuring world-first gaming monitors and a wireless Wallpaper TV that redefines performance and home design.

A startup's radical new model, born from a family's health crisis, directs all pediatric revenue to fund rare disease research and support families.

A new partnership brings the Aplio i800 EUS to the U.S., offering advanced imaging to improve early, less invasive diagnosis of complex GI conditions.

A new app for cleaning gravestones just won a major industry award. See how AI and a national network are changing how we care for departed loved ones.